FDA Clearance Tracker · K201633
Terason uSmart 3200T Plus Ultrasound System
Last checked: Nov 19, 2026Latest source record: Jul 2, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Jul 2, 2020
Substantially Equivalent
Time to decision
16 days
Received Jun 16, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K201633
- Device name
- Terason uSmart 3200T Plus Ultrasound System
- Applicant
- Teratech Corporation
- Applicant location
- Burlington, MA
- Received
- Jun 16, 2020
- Decided
- Jul 2, 2020
- Decision
- Substantially Equivalent
- Submission type
- Traditional
- Third-party review
- Yes. An FDA-accredited third party reviewed this submission before FDA decided.
Device type
- Device class
- Class II
- Regulation
- 21 CFR 892.1550
- Specialty
- Radiology & Imaging
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code IYN. The earliest in FDA's data is K781642, decided Oct 10, 1978.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K201633
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Teratech Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Terason uSmart3200T Ultrasound SystemThird-party review510(k)
K193510 · Decided Jan 28, 2020 · 41 days after receipt
Device type: System, Imaging, Pulsed Doppler, Ultrasonic (IYN) · Radiology & Imaging
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.